178 related articles for article (PubMed ID: 16500103)
1. Clostridium spores as anti-tumour agents.
Van Mellaert L; Barbé S; Anné J
Trends Microbiol; 2006 Apr; 14(4):190-6. PubMed ID: 16500103
[TBL] [Abstract][Full Text] [Related]
2. Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours.
Lambin P; Theys J; Landuyt W; Rijken P; van der Kogel A; van der Schueren E; Hodgkiss R; Fowler J; Nuyts S; de Bruijn E; Van Mellaert L; Anné J
Anaerobe; 1998 Aug; 4(4):183-8. PubMed ID: 16887640
[TBL] [Abstract][Full Text] [Related]
3. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
4. Clostridium as a tumor-specific delivery system of therapeutic proteins.
Theys J; Landuyt AW; Nuyts S; Van Mellaert L; Lambin P; Anné J
Cancer Detect Prev; 2001; 25(6):548-57. PubMed ID: 12132875
[TBL] [Abstract][Full Text] [Related]
5. Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas.
Theys J; Landuyt W; Nuyts S; Van Mellaert L; Bosmans E; Rijnders A; Van Den Bogaert W; van Oosterom A; Anné J; Lambin P
FEMS Immunol Med Microbiol; 2001 Feb; 30(1):37-41. PubMed ID: 11172989
[TBL] [Abstract][Full Text] [Related]
6. Clostridia in cancer therapy.
Minton NP
Nat Rev Microbiol; 2003 Dec; 1(3):237-42. PubMed ID: 15035028
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. A theoretical models of oncolysis by Clostridium oncolyticum M 55 ATCC 13,732.
Brantner H; Schwager J
Arch Geschwulstforsch; 1980; 50(7):601-12. PubMed ID: 6263207
[TBL] [Abstract][Full Text] [Related]
9. The use of clostridial spores for cancer treatment.
Barbé S; Van Mellaert L; Anné J
J Appl Microbiol; 2006 Sep; 101(3):571-8. PubMed ID: 16907807
[TBL] [Abstract][Full Text] [Related]
10. Cocultivation of Clostridium oncolyticum with normal and tumour cell lines.
Schlechte H; Baumbach L; Elbe B
Arch Geschwulstforsch; 1981; 51(1):51-7. PubMed ID: 7196212
[TBL] [Abstract][Full Text] [Related]
11. The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy.
Kubiak AM; Minton NP
Res Microbiol; 2015 May; 166(4):244-54. PubMed ID: 25576776
[TBL] [Abstract][Full Text] [Related]
12. The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
Schmidt W; Fabricius EM; Schneeweiss U
Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987
[TBL] [Abstract][Full Text] [Related]
13. [Serologic diagnosis of brain tumors using Clostridium butyrium spores (experimental and clinical studies)].
Krechmer Kh
Vopr Neirokhir; 1975; (5):24-8. PubMed ID: 173087
[TBL] [Abstract][Full Text] [Related]
14. [Experiments to improve the oncolysis-effect of clostridial-strain M55 (author's transl)].
Möse JR
Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):541-5. PubMed ID: 543354
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for tumours using clostridial oncolysis, antibiotics and cyclophosphamide: model trial on the UVT 15264 tumour.
Schlechte H; Schwabe K; Mehnert WH; Schulze B; Bräuniger H
Arch Geschwulstforsch; 1982; 52(1):41-8. PubMed ID: 7082130
[TBL] [Abstract][Full Text] [Related]
16. [Investigations on the characterization of a clostridial strain for tumour diagnosis (author's transl)].
Schau HP; Fabricius EM; Schneeweiss U; Benedix A
Zentralbl Bakteriol A; 1980 Feb; 246(1):80-97. PubMed ID: 7424236
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of
Sharafabad BE; Abdoli A; Abdolmohammadi Khiav L; Meskini M; Jamur P; Dilmaghani A
Curr Cancer Drug Targets; 2023; 23(9):682-696. PubMed ID: 37069721
[TBL] [Abstract][Full Text] [Related]
18. [Morphogenesis and function of gas caps on spores of anaerobic bacteria of the genus Clostridium].
Duda VI; Makar'eva ED
Mikrobiologiia; 1977; 46(4):689-94. PubMed ID: 909467
[TBL] [Abstract][Full Text] [Related]
19. [Treatment experiments with glucose-induced hyperglycaemia plus Clostridium-spores on the Jensen sarcoma of rats].
Hambsch K; Körner C; Ludewig R
Arch Geschwulstforsch; 1982; 52(4):267-73. PubMed ID: 7138239
[TBL] [Abstract][Full Text] [Related]
20. Conception and stages of development of the microbiological cancer test.
Schneeweiss U; Fabricius EM; Schmidt W
Arch Geschwulstforsch; 1986; 56(6):401-6. PubMed ID: 3827525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
